Clinical Trial Update: Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating artesunate-mefloquine as a novel alternative treatment for schistosomiasis in African children (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosoma Haematobium Infection
• Schistosoma Mansoni Infection
• Schistosomiasis

Drugs mentioned

• Artesunate-mefloquine (artesunate-mefloquine)

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Schistosoma Haematobium, Schistosoma Mansoni | Phase 3 | Status: COMPLETED